These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 5855716)

  • 21. Treatment of bleeding in dialysis patients.
    Galbusera M; Remuzzi G; Boccardo P
    Semin Dial; 2009; 22(3):279-86. PubMed ID: 19573008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Disorders of hemostasis and blood coagulation in uremia. II. Experimental study].
    Moriau M
    Rev Belg Pathol Med Exp; 1965 Dec; 31(5):406-19. PubMed ID: 5862550
    [No Abstract]   [Full Text] [Related]  

  • 23. Hemostatic disorder of uremia: the platelet defect, main determinant of the prolonged bleeding time, is correlated with indices of activation of coagulation and fibrinolysis.
    Mezzano D; Tagle R; Panes O; Pérez M; Downey P; Muñoz B; Aranda E; Barja P; Thambo S; González F; Mezzano S; Pereira J
    Thromb Haemost; 1996 Sep; 76(3):312-21. PubMed ID: 8883263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Acquired changes in platelet function].
    Lucia JF
    Sangre (Barc); 1984; 29(4-C):798-810. PubMed ID: 6096973
    [No Abstract]   [Full Text] [Related]  

  • 25. Adhesiveness of blood platelets in uremia.
    Salzman EW; Neri LL
    Thromb Diath Haemorrh; 1966 Jan; 15(1):84-92. PubMed ID: 5919812
    [No Abstract]   [Full Text] [Related]  

  • 26. [Dysfunction of platelets in uremia].
    Hryszko T; Małyszko J; Myśliwiec M
    Przegl Lek; 1999; 56(9):599-603. PubMed ID: 10695367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet coagulation-protein interactions.
    Walsh PN
    Semin Thromb Hemost; 2004 Aug; 30(4):461-71. PubMed ID: 15354267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemostatic problems in uremia.
    Haznedaroglu IC; Büyükaşik Y; Erdem Y
    Blood Purif; 1998; 16(4):220-1; discussion 221. PubMed ID: 9736791
    [No Abstract]   [Full Text] [Related]  

  • 29. Impact of automation on the quantitation of low molecular weight markers of hemostatic defects.
    Fareed J; Walenga JM; Bick RL; Bermes EJ; Messmore HL
    Semin Thromb Hemost; 1983 Oct; 9(4):355-79. PubMed ID: 6229030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The clinical significance of disorders in the hemostatic system in infectious endocarditis].
    Mil'to AS
    Ter Arkh; 1998; 70(8):54-6. PubMed ID: 9770747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hemostatic disturbances in obesity].
    Swiatkowska-Stodulska R; Kazimierska E; Sworczak K; Czestochowska E
    Wiad Lek; 2007; 60(3-4):185-8. PubMed ID: 17726874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The concepts of abnormal platelet morphology and function. "Platelet insufficiency" (thrombasthenia, thrombopathy)].
    Revol L
    Hemostase; 1965 Dec; 5(4):333-40. PubMed ID: 5880345
    [No Abstract]   [Full Text] [Related]  

  • 33. Hemostatic defects in massive transfusion: rapid diagnosis and management.
    Reiss RF
    Am J Crit Care; 2000 May; 9(3):158-65; quiz 166-7. PubMed ID: 10800600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current status of non-transfusional haemostatic agents.
    Cattaneo M; Mannucci PM
    Haematologica; 1999 Jun; 84 Suppl EHA-4():120-3. PubMed ID: 10907488
    [No Abstract]   [Full Text] [Related]  

  • 35. [Study of hemostasis and coagulation in uremic patients during extra-corporeal dialysis].
    Praga C; Brancaccio D; Cortellaro M; Pisani E; Della Grazia ME
    Minerva Nefrol; 1966; 13(4):122-33. PubMed ID: 5995533
    [No Abstract]   [Full Text] [Related]  

  • 36. [Study of the hemostatic platelet and plasma systems in patients with pulmonary tuberculosis].
    Kaminskaia GO; Serebrianaia BA; Martynova EV
    Probl Tuberk Bolezn Legk; 2007; (4):38-41. PubMed ID: 17657966
    [No Abstract]   [Full Text] [Related]  

  • 37. Blood viscosity and thrombosis: clinical considerations.
    Smith BD; La Celle PL
    Prog Hemost Thromb; 1982; 6():179-201. PubMed ID: 6762612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of uraemic thrombopathy (author's transl)].
    Castillo R; Ordinas A; Maragall S; Labal F; Lozano T; López J; Pons J; Revert L
    Sangre (Barc); 1980; 25(5B):730-8. PubMed ID: 7193356
    [No Abstract]   [Full Text] [Related]  

  • 39. [Disorders of hemostasis in liver cirrhosis. 2. Therapy].
    Neidhardt B; Schricker KT
    Fortschr Med; 1982 May; 100(18):836-40. PubMed ID: 6178666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Uraemic thrombocytopathy: a persistenly unknown matter (author's transl)].
    Giralt M
    Sangre (Barc); 1980; 25(5B):722-9. PubMed ID: 7193355
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.